Correlation Between ReShape Lifesciences and Helius Medical

Can any of the company-specific risk be diversified away by investing in both ReShape Lifesciences and Helius Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ReShape Lifesciences and Helius Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ReShape Lifesciences and Helius Medical Technologies, you can compare the effects of market volatilities on ReShape Lifesciences and Helius Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ReShape Lifesciences with a short position of Helius Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ReShape Lifesciences and Helius Medical.

Diversification Opportunities for ReShape Lifesciences and Helius Medical

0.09

Correlation Coefficient

ReShape Lifesciences  Helius Medical

Significant diversification

The 3 months correlation between ReShape and Helius is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding ReShape Lifesciences and Helius Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helius Medical Techn and ReShape Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ReShape Lifesciences are associated (or correlated) with Helius Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helius Medical Techn has no effect on the direction of ReShape Lifesciences i.e., ReShape Lifesciences and Helius Medical go up and down completely randomly.

Pair Corralation between ReShape Lifesciences and Helius Medical

Given the investment horizon of 90 days ReShape Lifesciences is expected to under-perform the Helius Medical. But the stock apears to be less risky and, when comparing its historical volatility, ReShape Lifesciences is 1.58 times less risky than Helius Medical. The stock trades about -0.21 of its potential returns per unit of risk. The Helius Medical Technologies is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  49.00  in Helius Medical Technologies on November 28, 2024 and sell it today you would earn a total of  2.00  from holding Helius Medical Technologies or generate 4.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	96.67%
Values	Daily Returns

ReShape Lifesciences  vs.  Helius Medical Technologies

ReShape Lifesciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Helius Medical Techn

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Helius Medical Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Helius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ReShape Lifesciences and Helius Medical

The main advantage of trading using opposite ReShape Lifesciences and Helius Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ReShape Lifesciences position performs unexpectedly, Helius Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helius Medical will offset losses from the drop in Helius Medical's long position.

The idea behind ReShape Lifesciences and Helius Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.